from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1266c/pknH

LFCtreatmentdescriptionclass of inhibitor

-0.211

Amikacinug/mL Amikacintranslation

-2.404

Cap5-10ug/mL Capreomycintranslation

-2.019

Rox10-50 ug/mL Roxithromycintranslation

-0.208

SM2-5 ug/mL Streptomycintranslation

-2.688

Tet5-10 ug/mL Tetracyclinetranslation

0.489

Rif0.2-5ug/mL Rifampicintranscription

1.537

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.317

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.036

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.427

CPZ10-50 ug/mL Chlorpromazinerespiration

1.631

Clofazimine10-13 ug/mL Clofaziminerespiration

0.542

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.022

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.059

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.177

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.498

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.928

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.007

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.205

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.240

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.815

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.862

Nigericin50 uM Nigericinrespiration

0.008

TRC10-150 ug/mL Triclosanrespiration

0.435

TRZ10-25 ug/mL Thioridazinerespiration

-0.773

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.328

menadione6-10 ug/mL Menadionerespiration

-0.145

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.383

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.193

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.757

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.489

NRP_1Non-replicating persistence stage 1dosRassociated

-0.037

Amp0.2mg/mL AmpicillincellWall

-0.439

Cephalexin20-100 ug/mL CephalexincellWall

-0.395

Cerulenin0.32-5 ug/mL CerulenincellWall

0.282

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.444

EMB10-20 ug/mL EthambutolcellWall

-0.529

Eta12-40 ug/mL EthionamidecellWall

-0.241

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.297

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.204

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.649

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.850

BZA0.12 mg/mL BenzamidearomaticAmides

0.646

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.483

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.179

H2O24 mM hydrogen peroxideDNAdamaging

-0.023

Levo10 ug/mL LevofloxacinDNAdamaging

-0.268

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.518

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.029

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.638

UVUV-irradiationDNAdamaging

-0.974

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.251

Antimycin12.5-50 ug/mL Antimycin A?

-0.707

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.050

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.864

PA8240.2-2 ug/mL PA-824?

-0.190

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.099

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.652

Verapamil50 uM Verapamil?

-0.311

mercaptoethanol2 mM 2-Mercaptoethanol?

0.042

methoxatin10-20 ug/mL Methoxatin?